# A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma

> **NCT01898598** · PHASE2 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 18 (actual)

## Conditions studied

- Basal Cell Carcinoma

## Interventions

- **DRUG:** Placebo
- **DRUG:** Vismodegib

## Key facts

- **NCT ID:** NCT01898598
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01-23
- **Primary completion:** 2016-01-26
- **Final completion:** 2016-01-26
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898598, "A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01898598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*